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Abstract
Background: Severe, chronic, and impairing irritability is a common presenting clinical problem in youth. Indeed, it
was recently operationalized as disruptive mood dysregulation disorder (DMDD) in the DSM-5. However, to date,
there are no evidence-based treatments that were specifically developed for DMDD. The current randomized
controlled trial assesses the efficacy of a computer-based cognitive training intervention (Interpretation Bias Training;
IBT) in youth with DMDD. IBT aims to reduce irritability by altering judgments of ambiguous face-emotions through
computerized feedback. IBT is based on previous findings that youth with irritability-related psychopathology rate
ambiguous faces as more hostile and fear producing.
Methods/design: This is a double-blind, randomized controlled trial of IBT in 40 youth with DMDD. Participants will
be randomized to receive four IBT sessions (Active vs. Sham training) over 4 days. Active IBT provides computerized
feedback to change ambiguous face-emotion interpretations towards happy interpretations. Face-emotion judgments
are performed pre and post training, and for 2 weeks following training. Blinded clinicians will conduct weekly clinical
ratings. Primary outcome measures assess changes in irritability using the clinician-rated Affective Reactivity Index (ARI)
and Clinical Global Impressions-Improvement (CGI-I) scale for DMDD, as well as parent and child reports of irritability
using the ARI. Secondary outcome measures include clinician ratings of depression, anxiety, and overall impairment.
In addition, parent and child self-report measures of depression, anxiety, anger, social status, and aggression will be
collected.
Discussion: The study described in this protocol will perform the first RCT testing the efficacy of IBT in reducing
irritability in youth with DMDD. Developing non-pharmacological treatment options for youth suffering from severe,
chronic irritability is important to potentially augment existing treatments.
Trial registration: ClinicalTrials.gov, ID: NCT02531893. Registered on 25 August 2015.
Keywords: Irritability, Children and adolescence, Cognitive training, Interpretation bias, Randomized controlled trial,
RCT, DMDD, Face-emotion
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Background
Irritability, defined as an increased proneness to anger
and outbursts relative to peers [1, 2], is highly prevalent
[3–7] and impairing in youth [8]. Irritability in youth
predicts the development of depression and anxiety [3,
4, 7], suicidality [9, 10], and is linked to overall reduced
academic and socioeconomic functioning [11]. Given the
functional impairment and association with negative
outcomes, chronic irritability is a significant public
health concern [3–5, 11, 12].
Despite this pressing clinical and public health need, there
is remarkably little treatment research on pathological irri-
tablity [1, 2, 13, 14]. Recently, disruptive mood dysregulation
disorder (DMDD), with a core feature of chronic irritability,
has been introduced into the Diagnostic and Statistical
Manual of Mental Disorders 5 (DSM-5 [15]). DMDD
provides a diagnostic category for trials of treatments
targeting severe and impairing irritability in youth that may
be readily translated into clinical practice. Currently,
non-pharmacological treatment strategies for DMDD are in-
vestigational, with no evidence-based cognitive trainings to
treat the irritability characteristic of DMDD.
Rational for treatment intervention
Clinically, irritability is characterized by a low threshold
for angry, reactively aggressive responses to provocations
[14]. One of the most established findings in youth with
irritability-related psychopathology is that they are more
likely to judge ambiguous social stimuli as hostile [14,
16]. Compared to healthy youth, chronically irritable
youth preferentially attend towards threatening (i.e.,
angry) faces [17], and rate ambiguous faces as
fear-inducing [18] or threatening (i.e., interpretation
bias; [19]). A substantial body of work has shown that
these biased interpretations of ambiguous social stimuli
elicit and potentiate angry, aggressive responses in youth
[16, 20]. Hence, biases in interpreting social stimuli may
serve to maintain irritability [14, 19] and provide a po-
tential target for novel interventions.
One promising set of novel interventions relies on
computer-based technology to change biases in informa-
tion processing through repeated exposure to “corrective”
feedback (e.g., [21]). This approach has shown promise in
the treatment of anxiety (e.g., [22]). In the study described
in this protocol, we will test whether such an approach
can be used to shift biased interpretations of
face-emotions in DMDD and thereby reduce irritability.
The Interpretation Bias Training (IBT) task [23] is a
method to both quantify and train face-emotion inter-
pretation bias. In this task, participants are presented
with face-emotions morphed from very happy to very
angry across a continuum of 15 stimuli (see Fig. 2 for ex-
ample stimuli). Participants are instructed to make
quick, binary happy-angry judgments for each face
morph that appears on the screen. Morphs are presented
in random order. Data indicate that both healthy partici-
pants and psychiatric patients categorize each morph re-
liably [23]. The morph in the continuum at which each
participant’s judgment switches from happy to angry has
been termed “balance point” (BP) and represents a
measure of interpretation bias. For instance, participants
who rate only a few faces along the happy-angry con-
tinuum as happy before switching their judgment to pre-
dominantly angry responses would have a low BP, i.e., an
increased bias towards perceiving ambiguous faces as
angry. This IBT task can also be used to change
face-emotion interpretations by providing trial-by-trial,
computer-based feedback to shift the participant’s BP
along the continuum of face morphs.
In other phenotypes in youth, such as disruptive behav-
ioral problems, preliminary data suggest that shifting par-
ticipants’ BP may reduce anger and aggression [24]. In a
randomized controlled trial (RCT) of 46 adolescents who
were in residential treatment because of aggressive behav-
ior and high-risk of criminal behavior, Penton-Voak et al.
[24] reported that four sessions of Active compared to
Sham training on the IBT task shifted participants’ BP to-
ward happy and away from angry judgments. Further, Ac-
tive training was associated with a significant reduction in
both self-rated anger and aggressive behavior rated by
blinded residential treatment staff.
In a recent preliminary study, Stoddard et al. [19] ex-
tended this work to youth with DMDD. In a series of pilot
experiments, Stoddard and colleagues demonstrated a dif-
ference in BP between DMDD (n = 63) and healthy youth
(n = 26), with DMDD youth exhibiting a bias towards
angry judgments. Additionally, Stoddard and colleagues
tested the feasibility of training irritable youth in an open
pilot trial. In 14 DMDD youth, four sessions of Active
training resulted in a shift in BP, which persisted for
2 weeks post training. Clinical data were consistent with
an improvement in parent-reported irritability over the
course of the open pilot trial. While promising, these data
are preliminary and do not test efficacy, supporting a test
of IBT on irritability in DMDD in a RCT. Thus, the ob-
jective of the current study, described in this protocol, is
to assess the efficacy of IBT in reducing irritability in
youth with DMDD in a double-blind, randomized,
placebo-controlled design. The IBT RCT compares Active
training, which encourages a shift in face-emotion inter-
pretations toward happy judgments, to Sham training,
where feedback does not encourage change in a person’s
pre-training face-emotion interpretations.
Methods/design
Design
The study described in this protocol performs a
double-blind RCT to test the efficacy of IBT as an
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augmentation to standard of clinical care (i.e., psycho-
tropic medications and/or psychotherapy) for DMDD (see
Fig. 1). Forty youth with current DMDD will be random-
ized (1:1) to receive four IBT sessions (Active vs. Sham, in
a double-blind design) over 4 days followed by weekly
mood ratings and BP assessments for 2 weeks. Primary
outcome measures in this trial assess changes in irritability
using the Clinician Affective Reactivity Index (Clinician
ARI) and Clinical Global Impressions-Improvement
for DMDD (CGI-I; [25]), as well as parent- and
child-report of irritability (child- and parent-rated ARI;
[26]). Additional file 1 provides the SPIRIT checklist for
this trial.
Recruitment
Patients will be recruited nationwide through Institutional
Review Board (IRB)-approved postcards, mailings, an-
nouncements in newsletters and bulletin boards or centers,
and contacts with support groups and approved websites.
Information leaflets may be posted electronically on web-
sites such as National Institutes of Health (NIH) or Na-
tional Institute of Mental Health (NIMH) websites,
advocacy support group websites (e.g., National Alliance on
Mental Illness (NAMI), Children and Adults with Attention
Deficit/Hyperactivity Disorder), publications’ websites (e.g.,
Washington Parent). Researchers (MAB) also give presenta-
tions to the public and mental health professionals regard-
ing our research and recruitment efforts for studies.
Informed consent and assent will be obtained from
parents and youth, respectively, before any trial-specific
procedures are performed. All participants will be ad-
vised that research is entirely voluntary, that they may
withdraw participation at any time. Families will be paid
for participation.
At screening and during enrollment of the IBT RCT,
participants will be informed of, and agree to, maintain
their current mental health treatment regimen 2 weeks
prior to the start of the IBT RCT and through the sec-
ond follow-up visit.
Participants
Inclusion criteria
Participants must be between the ages of 8–17 years
and currently meet full DSM-5 diagnostic criteria for
DMDD as assessed by a structured clinical interview
(Kiddie-Schedule for Affective Disorders and Schizo-
phrenia Present and Lifetime Version; K-SADS-PL;
[27]), with an additional supplement to assess the pres-
ence of DMDD [28]. Additionally, based on record re-
view and interviews with child and parent, the research
team must agree that the child’s response to their
current treatment is no more than minimal as opera-
tionalized by a DMDD CGI-S (1-month version) score
of 3 or more. Patients must be fluent in English; both
parents and youth must provide written informed con-
sent and assent, respectively.
Exclusion criteria
Participants will be excluded if the irritability symptoms
are due to the direct physiological effects of a drug, or
Fig. 1 Flow diagram of the Interpretation Bias Task randomized controlled trial (IBT RCT)
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to a general medical or neurological condition. Addition-
ally, participants will not be eligible if they meet DSM
5-criteria, as assessed by the K-SADS-PL (Kaufman et
al., 1997), for schizophrenia, schizophreniform disorder,
schizoaffective illness, autism spectrum disorder, post-
traumatic stress disorder, current major depressive dis-
order, or if they meet criteria for alcohol or substance
abuse 3 months prior to enrollment. Participants will be
excluded from the study if they exhibit cardinal bipolar
symptoms or have an IQ below 70 as assessed by the
Wechsler Abbreviated Scale of Intelligence (WASI;
[29]). Patients must not have planned changes in out-
patient psychiatric treatment regimen, which can include
psychotropic medications and/or psychotherapeutic in-
terventions, 2 weeks prior to enrollment and throughout
the 3 weeks of the RCT training and post-training
follow-up assessments.
Intervention
The IBT task assesses and trains happy-angry interpreta-
tions of face emotions. There are two versions of the
task, an assessment version (Assessment Task) and a
training version (Training Task, either Active or Sham).
The task stimuli for both tasks consist of the same set of
15 face-emotion pictures, or “face morphs” (see Fig. 2
for example stimuli [30]). Face morphs were created
from two prototypical happy and angry composite im-
ages of 20 individual male faces from the Karolinska Di-
rected Emotional Faces [24, 30]. These happy and angry
prototypical images were used as endpoints to generate
a continuum of 15 images from unambiguously happy to
unambiguously angry.
Assessment Task
In the Assessment Task, morphs are presented three
times in random order for a total of 45 trials. Each trial
consists of a fixation cross (1500–2500 ms), image pres-
entation (150 ms), visual noise mask (250 ms), and a
screen (no time limit) where a person is required to
make a forced-choice response of “happy” or “angry” via
keyboard button press. The Assessment Task takes ap-
proximately 2.5 min. The Assessment Task measures the
participant’s BP, i.e., the morph at which the participant
shifts their judgment from predominantly happy to pre-
dominately angry, with the continuum of morphs coded
on an integer scale from the happiest endpoint = 1 to the
angriest endpoint = 15. The BP can be estimated in real
time during a training session as the proportion of
happy responses to total responses multiplied by 15.
Training Task
The Assessment Task is administered before and after
each Training Task to measure BP pre and post each
training session. In both the Active and the Sham train-
ing version of the task, the stimuli and timing are the
same as the Assessment Task. The difference is that
feedback is provided to the participant on every trial
after their response. Feedback consists of a message say-
ing “Right!/Wrong!” Consistent with previous IBT trials
(e.g., [24]), in the Sham training, feedback is based on
the participant’s original BP, as measured using the As-
sessment Task before training (i.e., the feedback is con-
sistent with the participant’s pre-training BP). In the
Active training, feedback is based on a modified version
of the participant’s pre-training BP. Specifically, the Ac-
tive training is designed to shift the participant’s BP so
Fig. 2 Training is designed to shift pre-training balance point, thereby reducing an angry interpretation bias. Adapted with permission from the
authors [22]
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that two ambiguous morphs that were rated angry at pre
training will be rated as happy post training. The feed-
back is based on the participant’s pre-training BP; hence
two ambiguous images in the center of the morph con-
tinuum that the participant judged as angry pre training
will instead be considered happy for the purposes of
feedback. In the Training Task, each morph will be pre-
sented twice in random order to create a training block.
There are six training blocks of 30 trials each summing
to a total of 180 training trials.
Outcome measures
In addition to primary outcome measures assessing
changes in irritability (ARI and CGI-I), this trial includes
several secondary outcome measures. Secondary out-
come measures include clinician ratings of depression,
(Children’s Depression Rating Scale, CDRS; [31]), anxiety
(Pediatric Anxiety Rating Scale, PARS; [32]), and impair-
ment (Clinical Global Impressions-Severity for DMDD,
CGI-S; [25]; Children’s Global Assessment Scale, CGAS;
[33]). Additionally, parent-report measures of anxiety
(Screen for Childhood Anxiety Related Emotional
Disorders-parent, SCARED; [34]) and aggression (Modi-
fied Overt Aggression Scale, MOAS; [35]) and child
self-report measures of depression (Children’s Depres-
sion Inventory, CDI; [36]), anxiety (Screen for Childhood
Anxiety Related Emotional Disorders-child, SCARED;
[34]), anger (State-Trait Anger Expression Inventory-2
Child and Adolescent, STAXI-2 C/A; [37]). We will also
collect information on social status (Kids in My Class
Questionnaire, [38]; MacArthur Scale of Subjective
Social Status; [39]) and intent attributions (Hostile
Attribution Bias [HAB]) using a hypothetical-situations
instrument [40].
Study procedure
Figure 1 provides a flow diagram of the study design, Fig. 3
provides a detailed schedule of enrollment, interventions
and assessments. Participants will first complete a
pre-training clinical screening before being enrolled in the
protocol and randomized. Participants will be allocated to
receive four IBT sessions (Active vs. Sham training in a
double-blind design) over 4 days. Participants will
complete a series of clinician- and self-report ratings pre
and post training days followed by weekly clinical ratings
and BP assessments for two additional weeks post train-
ing. The endpoint for primary outcome measures will be
the DMDD CGI-I and ARI on the first follow-up visit (i.e.,
day 11). Figure 3 provides an overview of clinician-, par-
ent-, and child self-report measures administered at the
different time points. Participants’ intervention allocation
for the entire cohort will only be unblinded upon comple-
tion of the IBT study.
Pre-training screening visit
Participants and their parents will visit the NIH for a
pre-training clinical assessment to determine eligibility
to enroll in the IBT RCT. A trained masters- or
doctoral-level clinician will conduct interviews with the
participant and their parent including a current diagnos-
tic interview (i.e., K-SADS-PL) and a clinical rating on
the DMDD CGI-S.
Training visits (days 1–4)
Custom IBT software, written in Tcl (www.tcl.tk) (see also
[19]), will be packaged with stimuli for Mac and PC com-
puters. During visit day 1, participants will complete the
first session of IBT using either their own laptop com-
puter or a NIH computer. All IBT data will be quality
checked post training. Stimulus presentation timings will
be inspected for each training session to ensure that tim-
ing of face displays is precise on non-NIH equipment.
During this visit, participants and their parents are inter-
viewed by clinicians for clinical ratings for irritability
(cARI), depression CDRS), anxiety (PARS), overall func-
tional impairment (CGAS), and severity of irritability and
outbursts (CGI-S for DMDD, 1-week version). Partici-
pants and parents will also complete self-report forms. On
day 2 and day 3, participants will complete one session of
IBT, both sessions will be completed at home. The final
training session on day 4 will again be onsite. On day 4,
the participant and their parent will again be interviewed
by clinicians for clinical ratings for irritability (cARI), de-
pression (CDRS), anxiety (PARS), overall functional im-
pairment (i.e., CGAS), severity of irritability and outbursts
(CGI-S for DMDD), and improvement (CGI-I for
DMDD). The CGI-I interval will cover the time from day
1 through day 4, and the rating will be relative to the
day-1 CGI-S. During this visit, participants and parents
will again complete all self-report forms. To allow for rea-
sonable flexibility, during days 1–4, participants may re-
schedule up to two training sessions by extending the
training period to day 5 or 6 to complete four once-daily
sessions within a 6-day window. The participant com-
pletes rescheduled training sessions at home and self- and
parent-report measures will be completed online. Clinical
ratings may be done by phone.
Follow-up visits
1-week post training (day 11)
This follow-up visit determines whether training effects
persist for 1 week. Participants will begin this visit with an
onsite Assessment Task to measure BP. Next, the partici-
pant and their parents will be interviewed for clinical rat-
ings. The CGI-I interval is the past week, and the rating is
relative to the day 1 CGI-S. During this visit, participants
and parents will complete the same self-report measures.
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2-weeks post training (day 18)
This follow-up is completed from home and deter-
mines whether training effects persist for 2 weeks.
Participants will begin this session with an Assess-
ment Task to measure BP. Next, the participant and
their parent will be interviewed for clinical ratings.
The CGI-I interval is the past week, and the rating is
relative to the day-1 CGI-S. Participants and parents
will complete self-report measures online.
Allocation
Intervention allocation sequence will be created via a
computer-based random number generator. Randomization
will be performed in blocks of 10 participants with a 1:1 ratio
within blocks. Study personnel not involved in other aspects
of the study will perform randomization. The document with
the allocation sequence will be unavailable to those that en-
roll or otherwise interact with study participants. Training
tasks will be prepared by study personal not otherwise
Fig. 3 Schedule of enrollment, interventions, and assessments
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involved in the study and IBT training tasks (Active vs.
Sham) will be formatted identically. Trial participants, out-
come assessors, data analysts, and research assistants inter-
acting with families will be blind to participants’ intervention
allocation. The blind is not broken for the entire cohort until
completion of the IBT RCT.
Statistical analyses
Analysis of data/study outcomes
Primary outcome measures are ARI and CGI-I. We will
analyze both primary outcomes measures as a function of
training group (Active vs. Sham) and time point (pre
training and 1 week following training (day 11)). All data
will be analyzed in accordance with the intention-to-treat
principle. Following Stoddard et al. [19] and Pollak and
Kistler [41], we will fit a logistic curve to the binary
happy-angry judgment data to derive the BP. We will
examine associations among BP, clinical ratings, and treat-
ment condition. We expect any symptom changes in the
Active training group to be associated with shifts in BP.
Power analysis
The open pilot trial [19] found a large effect of IBT on
outcome (d = 1.2 for CGI-I). Because studies with similar
computer-based approaches (see [42] for a meta-analysis)
have found more moderate effect sizes in RCTs, we expect
an effect size of d = 0.8 to d = 1.0. Power analyses suggest
that 20 per group will be sufficient to detect differences at
alpha = 0.05, beta = 0.20. Dropouts will be replaced for an
n = 40 of participants who completed the trial.
Ethics
Study procedures were approved by the National Institute
of Mental Health (NIMH) Institutional Review Board
(IRB). Risks associated with participation in this RCT are
considered minimal. Adverse experiences include mild
psychological distress and discomfort when responding to
interview questions or completing questionnaires, or
boredom during the IBT task. The principal and associate
investigators will monitor patients closely throughout
their participation in the RCT. After completing the RCT,
all participants will be offered four Open Active IBT ses-
sions, delivered on the same schedule as in the RCT and
using the same primary outcome measures. For the Open
Active IBT, while the principal and associate investigators
will continue to monitor the patient, community providers
are overseeing the patients’ care.
Participants will be informed of their RCT interven-
tion allocation upon completion of the trial.
An independent safety monitor will surveil data and
safety. Audits of this treatment protocol will be con-
ducted on a regular basis.
Discussion
This study is the first RCT of IBT in youth with DMDD.
Chronic irritability, such as observed in DMDD, is se-
vere and impairing for affected youth and their families,
yet available treatment options are limited (Brotman et
al., 2017). The inclusion of DMDD in the DSM-5 dem-
onstrates the need to develop evidence-based treatments
to target severe, pathological irritability. The current
protocol describes the first double-blind RCT aimed to
test the efficacy of IBT in reducing irritability in youth
with DMDD. Forty youth are randomized to receive either
four Active IBT or Sham IBT sessions in a double-blind
design. Active IBT is designed to shift participants’
pre-training BP along a face-morph continuum towards
making increasingly happy judgments on ambiguous face
morphs. Sham training does not change the participants’
pre-training BP. BP is measured 2 weeks following treat-
ment. Primary outcome measures assess changes in irrit-
ability pre to post training and 2 weeks after training
using the clinician ARI and CGI-I for DMDD, as well as
parent- and child-reports of irritability using the ARI. Sec-
ondary outcome measures include clinician ratings of de-
pression, anxiety, and impairment. Parent- and child
self-report measures of depression, anxiety, anger, social
status, and aggression are also collected.
In this RCT, IBT is an augmentation to stable commu-
nity treatment (pharmacological and/or psychosocial).
Developing non-pharmacological treatment options for
youth suffering from severe, chronic irritability is par-
ticularly important to minimize psychotropic medication
exposure with profound side effects on the developing
brain. Additionally, computer-based interventions have
the potential to help bridge the treatment gap in psycho-
logical care as an easily accessible, cost-effective tool.
Trial status
The protocol (15-M-0182, Psychological Treatments for
Youth with Severe Irritability) received final IRB ap-
proval in August 2015, after which trial recruitment
commenced. Recruitment is expected to be completed
by January 2019.
Limitations
This study has several limitations. First, the sample size
is modest to investigate potentially small therapeutic ef-
fects. Second, follow-up ratings will be conducted over 2
weeks following the intervention. Therefore, the study is
limited in its ability to assess longer- term or delayed ef-
fects on symptoms. Third, we will not test near or far
transfer of learning; face interpretations are trained and
tested on the same face set. Should we find significant
symptom reductions in the training group, examining
whether training effects (i.e., changes in BP) generalize
to new face stimuli would be a crucial next step to
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provide evidence for the mechanism by which active
IBT may be efficacious. Lastly, we will only assess IBT as
an add-on to stable community treatment. Participants
enrolled in the trial will be concurrently taking a variety
of different medications, including psychotropic medica-
tions. However, as discussed, we do require medications
to remain stable throughout the trial.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Study protocol for a double-blind,
randomized, placebo-controlled trial of a computer-based Interpretation Bias
Training for youth with severe irritability. (DOC 123 kb)
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